TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $880,015 | +345.6% | 36,500 | +170.4% | 0.00% | – |
| Q1 2023 | $197,505 | +68.8% | 13,500 | +11.8% | 0.00% | – |
| Q1 2022 | $117,000 | -70.7% | 12,080 | +1.6% | 0.00% | – |
| Q3 2021 | $399,000 | +18.0% | 11,892 | +37.2% | 0.00% | – |
| Q2 2021 | $338,000 | -72.3% | 8,666 | -65.7% | 0.00% | -100.0% |
| Q1 2021 | $1,220,000 | -66.1% | 25,300 | -63.4% | 0.00% | -80.0% |
| Q4 2020 | $3,600,000 | +205.9% | 69,200 | +57.3% | 0.01% | +150.0% |
| Q3 2020 | $1,177,000 | +51.1% | 44,000 | +10.0% | 0.00% | +100.0% |
| Q2 2020 | $779,000 | -33.1% | 40,000 | -62.5% | 0.00% | -50.0% |
| Q4 2019 | $1,164,000 | +802.3% | 106,691 | +363.9% | 0.00% | – |
| Q3 2019 | $129,000 | -52.2% | 23,000 | -26.4% | 0.00% | – |
| Q2 2019 | $270,000 | +13.0% | 31,229 | +4.9% | 0.00% | – |
| Q1 2019 | $239,000 | +20.7% | 29,761 | -16.0% | 0.00% | – |
| Q3 2018 | $198,000 | -55.9% | 35,425 | +3.5% | 0.00% | -100.0% |
| Q2 2018 | $449,000 | – | 34,239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |